换一批Drug induced shortening of the QT/QTc interval: an emerging safety issue warranting further modelling and evaluation in drug research and development?
第一作者：
Mark,Holbrook
第一单位：
Pfizer, Global Safety Pharmacology, Pfizer, PGRD, Sandwich, Kent, UK. mark.holbrook@pfizer.com
作者：
医学主题词
动作电位(Action Potentials);心律失常, 心性(Arrhythmias, Cardiac);生物学标记, 药理学(Biomarkers, Pharmacological);临床试验(主题)(Clinical Trials as Topic);药物发现(Drug Discovery);药物评价, 临床前(Drug Evaluation, Preclinical);心电描记术(Electrocardiography);人类(Humans);QT延长综合征(Long QT Syndrome);苏格兰(Scotland)
DOI
10.1016/j.vascn.2008.09.001
PMID
18834945
发布时间
2018-12-01
- 浏览4
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
